Ads
related to: sanofi pharmaceuticals- Pharmaceutical Disposal
Compliant Returns and
Drug Waste Management
- Sharps Management
Sharps Collection & Disposal
Keeping Staff & Patients Safe
- Healthcare Offices
Ensure the Safe Disposal of Sharps,
Mercury, & Amalgam.
- OSHA and HIPAA Compliance
Complete Your Assessment Now
Assess in Less Than 5 Minutes
- Biohazard Disposal
Transportation & Disposal
for Regulated Waste Streams
- Compliance Training
Navigate the Regulatory Maze
with Expert Compliance Resources
- Pharmaceutical Disposal
Search results
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 2 hours agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 2 hours agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
Sanofi's Dupixent Drug Review Date Extended by Three Months in the U.S.
Market Watch· 10 hours agoFrench pharmaceutical company Sanofi said that the priority review date in the U.S. for its chronic obstructive pulmonary disease treatment, Dupixent has ...
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via Yahoo News· 11 hours agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
Benzinga· 40 minutes agoOn Friday, the FDA extended the target action date of priority review of supplemental application...
Pharma Stock Roundup: JNJ, MRK M&A Deals, SNY, RHHBY Drugs' Priority Review & More
Zacks via Yahoo Finance· 3 hours agoJ&J (JNJ) and Merck (MRK) announce the acquisitions of private biotechs. The FDA grants Priority...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 11 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration (FDA) has extended by three months the target ...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 4 days agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
Sanofi’s CEO thinks OpenAI offers 'insane' potential for thepharmaceutical industry
Fortune· 2 days agoIf generative AI is going to be more than hype and hallucinations, the trillion-dollar pharma industry is where the magic may happen. Last week, Hudson proudly announced his company’s new partnership ...
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 3 days agoTo streamline the process of bringing new medicines to patients, the companies will combine their...
Ad
related to: sanofi pharmaceuticals